Drug recall

Apheresis Red Blood Cells, Leukocytes Reduced

FDA recall event 89279 · Class II · The American National Red Cross - Southern Region

Key facts

Event ID 89279
Recall numbers B-0164-2022, B-0165-2022
Recalling firm The American National Red Cross - Southern Region
Product type Biologics
Products Apheresis Red Blood Cells, Leukocytes Reduced, Red Blood Cells, Leukocytes Reduced
Classification Class II
Status Terminated
Voluntary or mandated Voluntary: Firm Initiated
Reason for recall Misbranded Blood Products were distributed.
Initiation date Sep 9, 2021
Report date Jan 26, 2022
Termination date Jan 18, 2022
City Douglasville
State GA
Country United States
FEI number 1073000

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls